Brief: Chordate Medical Holding: Patient Study On Chronic Migraine Resumed In Germany

Chordate Medical Holding AB (publ)

19/05/2021 06:41

May 19 (Reuters) - Chordate Medical Holding AB (publ)
 CMHM.NGM :
    * SAID ON TUESDAY THE GERMAN CLINIC ANNOUNCES THAT THEY CAN
RESUME
THEIR PART OF THE PATIENT STUDY
    * THE FINNISH CLINICS HAVE PREVIOUSLY ANNOUNCED THAT THEY
HAVE
RESUMED WORK
    * THE STUDY ON THE PATENTED TREATMENT METHOD K.O.S AGAINST
CHRONIC
MIGRAINE, WHICH IS BEING CARRIED OUT AT SEVERAL CLINICS IN
GERMANY AND FINLAND, WAS LARGELY SUSPENDED DUE TO THE COVID-19
PANDEMIC IN 2020
    * THE ENTIRE STUDY IS NOW EXPECTED TO TREAT THE LAST
PATIENTS
DURING THE THIRD QUARTER OF 2021

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nBQN683hfw
 Further company coverage:  CMHM.NGM  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))